Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Clinical trial NCT02138825 · TERMINATED
Trial details
- NCT number
- NCT02138825
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-04
- Primary completion
- 2016-05-05
- Enrollment
- 147
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.